<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab1">
 <label>Table 1</label>
 <caption>
  <p>Pharmacological agents being investigated against COVID-19</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th align="left">Agent</th>
    <th align="left">Pharmacological class</th>
    <th align="left">Mode of action</th>
    <th align="left">Country where trials are registered against COVID-19</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="left">Anakinra</td>
    <td align="left">Interleukin-1 receptor antagonist</td>
    <td align="left">Suppresses cytokine storming</td>
    <td align="left">Not registered yet</td>
   </tr>
   <tr>
    <td align="left">Umifenovir</td>
    <td align="left">Antiviral/used against influenza</td>
    <td align="left">Inhibits fusion</td>
    <td align="left">China</td>
   </tr>
   <tr>
    <td align="left">Baricitinib</td>
    <td align="left">Treats rheumatoid arthritis</td>
    <td align="left">A Janus kinase family (JAK) enzyme inhibitor</td>
    <td align="left">Not registered yet</td>
   </tr>
   <tr>
    <td align="left">Bevacizumab</td>
    <td align="left">Recombinant humanized monoclonal antibody/used against cancer</td>
    <td align="left">Prevents vascular endothelial growth factor associated with endothelial receptors Flt-1 and KDR</td>
    <td align="left">China</td>
   </tr>
   <tr>
    <td align="left">Brilacidin</td>
    <td align="left">Antibiotic</td>
    <td align="left">A host defense peptide mimetic</td>
    <td align="left">USA</td>
   </tr>
   <tr>
    <td align="left">Convalescent plasma</td>
    <td align="left">From patients who have recovered from viral infections</td>
    <td align="left">Via production of antibodies against a disease agent</td>
    <td align="left">Not registered yet</td>
   </tr>
   <tr>
    <td align="left">Darunavir/cobicistat</td>
    <td align="left">Anti-retroviral</td>
    <td align="left">HIV-1 protease inhibitor</td>
    <td align="left">Not registered yet</td>
   </tr>
   <tr>
    <td align="left">Disulfiram</td>
    <td align="left">Thiuram derivative</td>
    <td align="left">Blocks alcohol oxidation</td>
    <td align="left">Not registered yet</td>
   </tr>
   <tr>
    <td align="left">Eculizumab</td>
    <td align="left">Humanized, monoclonal IgG antibody</td>
    <td align="left">Binds to complement protein C5 and prevents the formation of membrane attack complex</td>
    <td align="left">USA</td>
   </tr>
   <tr>
    <td align="left">Favipiravir</td>
    <td align="left">Antiviral/used against Ebola</td>
    <td align="left">RNA-dependent RNA polymerase inhibitor</td>
    <td align="left">USA</td>
   </tr>
   <tr>
    <td align="left">Galidesivir (BCX4430)</td>
    <td align="left">Antiviral/used against Ebola</td>
    <td align="left">Nucleoside RNA polymerase inhibitor</td>
    <td align="left">USA</td>
   </tr>
   <tr>
    <td align="left">Griffithsin</td>
    <td align="left">Anti-HIV microbicide</td>
    <td align="left">Potent HIV entry inhibitor</td>
    <td align="left">Not registered yet</td>
   </tr>
   <tr>
    <td align="left">Nelfinavir</td>
    <td align="left">Anti-retroviral</td>
    <td align="left">An HIV-1 protease inhibitor</td>
    <td align="left">Not registered yet</td>
   </tr>
   <tr>
    <td align="left">Niclosamide</td>
    <td align="left">Anthelminthic</td>
    <td align="left"/>
    <td align="left">Not registered yet</td>
   </tr>
   <tr>
    <td align="left">REGN3048</td>
    <td align="left">Human monoclonal antibody</td>
    <td align="left">Binds to S protein of MERS-CoV</td>
    <td align="left">USA</td>
   </tr>
   <tr>
    <td align="left">Sarilumab</td>
    <td align="left">Human monoclonal antibody/ used against rheumatoid arthritis</td>
    <td align="left">IL-6 receptor antagonist</td>
    <td align="left">USA</td>
   </tr>
   <tr>
    <td align="left">Sofosbuvir</td>
    <td align="left">Antiviral</td>
    <td align="left">A nucleotide analog inhibitor of hepatitis C virus</td>
    <td align="left">Not registered yet</td>
   </tr>
   <tr>
    <td align="left">TZLS-501</td>
    <td align="left">Human monoclonal antibody</td>
    <td align="left">Anti-IL6R</td>
    <td align="left">Not registered yet</td>
   </tr>
   <tr>
    <td align="left">XueBiJing</td>
    <td align="left">Anti-pneumonia</td>
    <td align="left">Treats sepsis</td>
    <td align="left">China</td>
   </tr>
  </tbody>
 </table>
</table-wrap>
